1. | chaiwen1675 | |
2. | Altenergy | |
3. | romam | |
4. | tmcaliendo | |
5. | hsheehan1684 |
1. | chaiwen1675 | |
2. | Altenergy | |
3. | romam | |
4. | tmcaliendo | |
5. | hsheehan1684 |
1. | romam 01/18/2018 Leading Leukemia Experts Join Moleculin's Science Advisory Board |
2. | romam 02/15/2018 Saw that |
3. | chaiwen1675 02/15/2018 Exciting news |
4. | Altenergy 02/15/2018 It's time to sell, heading down the whole day |
5. | tmcaliendo 03/27/2018 Moleculin Enters Agreement with Seidman Cancer Center to Conduct Leukemia Clinical Trials |
6. | hsheehan1684 06/13/2018 Developing Cancer Treatment Trials Positive Indication for Biotech Market |
7. | chaiwen1675 01/10/2018 Super news out! - Moleculin Expands Leukemia Development Portfolio with Immuno-Stimulating STAT3 Inhibitor |
8. | chaiwen1675 03/20/2018 Moleculin Announces Grant-Funded Collaboration to Expand Understanding of New Discovery |
9. | romam 06/07/2018 Moleculin's Breakthrough Discovery of a New Molecule for Cancer Treatment Advances to Development Agreement with the University of Iowa |
10. | romam 06/26/2018 Moleculin Selected for the Russell Microcap Index |